These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3000814)

  • 1. Effect of pyrophosphate and orotidine monophosphate on cytosine deaminase regulatory properties.
    West TP
    Experientia; 1985 Dec; 41(12):1563-4. PubMed ID: 3000814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and some properties of cytosine deaminase from Salmonella typhimurium.
    West TP; Shanley MS; O'Donovan GA
    Biochim Biophys Acta; 1982 Nov; 719(2):251-8. PubMed ID: 6758859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiles of pyrimidine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
    Katahira R; Ashihara H
    Planta; 2002 Sep; 215(5):821-8. PubMed ID: 12244448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repression of cytosine deaminase by pyrimidines in Salmonella typhimurium.
    West TP; O'Donovan GA
    J Bacteriol; 1982 Mar; 149(3):1171-4. PubMed ID: 7037740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of orotidine-5'-phosphate decarboxylase by 1-(5'-phospho-beta-d-ribofuranosyl)barbituric acid, 6-azauridine 5'-phosphate, and uridine 5'-phosphate.
    Levine HL; Brody RS; Westheimer FH
    Biochemistry; 1980 Oct; 19(22):4993-9. PubMed ID: 7006681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrimidine synthesis in Burkholderia cepacia ATCC 25416.
    Li K; West TP
    Lett Appl Microbiol; 1995 Nov; 21(5):340-3. PubMed ID: 7576530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deoxycytidine triphosphate deaminase of Salmonella typhimurium. Purification and characterization.
    Beck CF; Eisenhardt AR; Neuhard J
    J Biol Chem; 1975 Jan; 250(2):609-16. PubMed ID: 234434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transition state structure of Salmonella typhimurium orotate phosphoribosyltransferase.
    Tao W; Grubmeyer C; Blanchard JS
    Biochemistry; 1996 Jan; 35(1):14-21. PubMed ID: 8555167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escherichia coli cytosine deaminase: the kinetics and thermodynamics for binding of cytosine to the apoenzyme and the Zn(2+) holoenzyme are similar.
    Porter DJ
    Biochim Biophys Acta; 2000 Feb; 1476(2):239-52. PubMed ID: 10669789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central action of cyclic: 3',5'-thymidine, 3',5'-uridine and 3',5'-citidine monophosphates in rat.
    Brus R; Herman ZS; Juraszczyk Z; KrzemiƄski T; Trzeciak H; Kurcok A
    Acta Med Pol; 1984; 25(1-4):1-9. PubMed ID: 6100154
    [No Abstract]   [Full Text] [Related]  

  • 11. Enzymatic coupled assay procedures that employ high-performance liquid chromatography: the synthesis of orotidylate from ribose.
    Ashton RW; Sloan DL
    J Chromatogr; 1984 Dec; 317():245-50. PubMed ID: 6085083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repression of enzyme synthesis of the pyrimidine pathway in Salmonella typhimurium.
    Williams JC; O'Donovan GA
    J Bacteriol; 1973 Sep; 115(3):1071-6. PubMed ID: 4580556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alkylated cytosine nucleosides: substrate and inhibitor properties in enzymatic deamination.
    Krajewska E; Shugar D
    Acta Biochim Pol; 1975; 22(2):185-94. PubMed ID: 1098340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of yeast cytosine deaminase by 5-bromo-2-pyrimidinone and its covalent hydrate.
    Kornblatt MJ; Tee OS
    Eur J Biochem; 1986 Apr; 156(2):297-300. PubMed ID: 3516692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion of UMP, an allosteric inhibitor of carbamyl phosphate synthetase, to an activator by modification of the UMP ribose moiety.
    Boettcher B; Meister A
    J Biol Chem; 1981 Jun; 256(12):5977-80. PubMed ID: 7240186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covalent modification of the beta-1,4-N-acetylmuramoylhydrolase of Streptococcus faecium with 5-mercaptouridine monophosphate.
    Dolinger DL; Schramm VL; Shockman GD
    Proc Natl Acad Sci U S A; 1988 Sep; 85(18):6667-71. PubMed ID: 3413115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic resistance to tight-binding inhibitors of enzymes involved in the de novo pyrimidine pathway. Simulation of time-dependent effects.
    Duggleby RG; Christopherson RI
    Eur J Biochem; 1984 Aug; 143(1):221-6. PubMed ID: 6468388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and partial characterization of a 5'-nucleotidase specific for orotidine-5'-monophosphate.
    El Kouni MH; Cha S
    Proc Natl Acad Sci U S A; 1982 Feb; 79(4):1037-41. PubMed ID: 6280163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and inhibition of orotidine 5'-monophosphate decarboxylase from Plasmodium falciparum.
    Langley DB; Shojaei M; Chan C; Lok HC; Mackay JP; Traut TW; Guss JM; Christopherson RI
    Biochemistry; 2008 Mar; 47(12):3842-54. PubMed ID: 18303855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of inhibitors of orotidine monophosphate decarboxylase using bioisosteric replacement and determination of inhibition kinetics.
    Poduch E; Bello AM; Tang S; Fujihashi M; Pai EF; Kotra LP
    J Med Chem; 2006 Aug; 49(16):4937-45. PubMed ID: 16884305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.